A Resource for Healthcare and Social Services Professionals
This training, part two in a four-part series, will provide a brief overview of the history, legislation, pharmacodynamics, and pharmacokinetics of buprenorphine and naloxone.
This course series will prepare nurses and other key members of the multidisciplinary care team to deliver medication for opioid use disorder (MOUD), such as buprenorphine and naltrexone, using a chronic care management model. Topics covered will include the science of addiction as a brain disorder, the pharmacotherapy of medications used to treat opioid and alcohol use disorders (current standard of care), and practical tools for implementing these treatment modalities into an office-based setting and for supporting physicians and advanced practice providers as part of a care team. Attendees will learn to screen patients for substance use disorders, initiate medication, and provide ongoing care and counseling.
The learner will: explain the role of medication treatment; describe the fundamentals of the medications available; and identify the clinically relevant pharmacological characteristics of methadone, buprenorphine/naloxone and naltrexone.
Staff of the Community Clinic of Maui dba Mālama I Ke Ola Health Center
State Targeted Response Technical Assistance Consortium, Opioid Response Network, Substance Abuse and Mental Health Services Administration
Boston Medical Center grants 1.0 hours to all nurses who attend, complete the evaluation, and complete the post test. Boston Medical Center is approved as a provider of continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.